A cost-utility analysis of drug treatments in patients with HBeAg-positive chronic hepatitis B in Thailand.

Tantai, Narisa

A cost-utility analysis of drug treatments in patients with HBeAg-positive chronic hepatitis B in Thailand. [electronic resource] - BMC health services research Apr 2014 - 170 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1472-6963

10.1186/1472-6963-14-170 doi


Adenine--analogs & derivatives
Adult
Antiviral Agents--economics
Cost-Benefit Analysis
Drugs, Essential--economics
Female
Health Services Research
Hepatitis B e Antigens
Hepatitis B, Chronic--drug therapy
Humans
Lamivudine--economics
Male
Markov Chains
Models, Economic
Organophosphonates--economics
Quality-Adjusted Life Years
Tenofovir
Thailand--epidemiology
Treatment Outcome